ABG WTT-MedAvail Ltd - 04 Apr 2022 Form 4 Insider Report for MedAvail Holdings, Inc.

Role
10%+ Owner
Signature
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. By: ABG-WTT Global Life Science Capital Partners GP, L.P., its general partner By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner By: /s/ Fan Yu, Director
Issuer symbol
N/A
Transactions as of
04 Apr 2022
Net transactions value
+$22,499,997
Form type
4
Filing time
06 Apr 2022, 16:30:30 UTC
Next filing
15 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDVL Common Stock Purchase $11,840,000 +11,143,529 +287% $1.06 15,029,480 04 Apr 2022 See footnote F1
transaction MDVL Common Stock Purchase $3,159,999 +2,974,117 +102% $1.06 5,894,897 04 Apr 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDVL Warrant (Right to Buy) Purchase $5,919,999 +5,571,764 $1.06 5,571,764 04 Apr 2022 Common Stock 5,571,764 $1.25 See footnote F1
transaction MDVL Warrant (Right to Buy) Purchase $1,579,999 +1,487,058 $1.06 1,487,058 04 Apr 2022 Common Stock 1,487,058 $1.25 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held of record by ABG WTT-MedAvail Limited ("ABG WTT"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership.
F2 These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. ("MedAlpha"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership. As a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein.